Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 13;16(6):705.
doi: 10.3390/genes16060705.

Human CD36: Gene Regulation, Protein Function, and Its Role in Atherosclerosis Pathogenesis

Monika Rac  1
Affiliations
Review

Human CD36: Gene Regulation, Protein Function, and Its Role in Atherosclerosis Pathogenesis

Monika Rac. Genes (Basel). .

Abstract

Human CD36 plays an important role in ligand binding, signalling, cell adhesion, and the regulation of angiogenesis. As a scavenging receptor, it is responsible for clearing long-chain fatty acids (LCFAs) and removing approximately 50% of oxidised low-density lipoprotein (ox-LDL) from plasma. The CD36 gene is alternatively spliced. It has several alternative promoters and first exons. The alternative transcripts are expressed in multiple tissues, and their expression patterns are highly variable. The molecular mechanisms that regulate CD36 gene expression are complex and reflect its multifunctional role in different tissues. CD36 activity has been linked to several metabolic processes, such as inflammation, angiogenesis, phagocytosis, and energy homeostasis. CD36 plays a key role in regulating vascular and cardiovascular health and in the pathogenesis of atherosclerosis. CD36 gene mutations in the Caucasian population are rare. Hence, it is extremely difficult to recruit a statistically significant group of CAD patients with these mutations. Nevertheless, this population is largely at risk of cardiovascular disease. Atherosclerosis is a multifactorial disease, but the role of the CD36 receptor in the development of ox-LDL is extremely important. This review aims to introduce readers to issues related to the relationship between CD36 and CAD. The activity of this receptor should be considered when exploring treatment options for atherosclerosis-related complications.

Keywords: CD36; atherosclerosis; ox-LDL receptor.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflicts of interest.

Figures

Figure 1
Figure 1
The structure of the CD36 protein.
Figure 2
Figure 2
Signalling through CD36 in platelets.
Figure 3
Figure 3
The signalling pathway triggered by oxLDL internalisation into the CD36 receptor.
See this image and copyright information in PMC

References

    1. Stone P.H., Libby P., Boden W.E. Fundamental Pathobiology of Coronary Atherosclerosis and Clinical Implications for Chronic Ischemic Heart Disease Management-The Plaque Hypothesis: A Narrative Review. JAMA Cardiol. 2023;8:192–201. doi: 10.1001/jamacardio.2022.3926. - DOI - PMC - PubMed
    1. Osterud B., Bjorklid E. Role of monocytes in atherogenesis. Physiol. Rev. 2003;83:1069–1112. doi: 10.1152/physrev.00005.2003. - DOI - PubMed
    1. Kong P., Cui Z.Y., Huang X.F., Zhang D.D., Guo R.J., Han M. Inflammation and atherosclerosis: Signaling pathways and therapeutic intervention. Signal Transduct. Target. Ther. 2022;7:131. doi: 10.1038/s41392-022-00955-7. - DOI - PMC - PubMed
    1. Soehnlein O., Libby P. Targeting inflammation in atherosclerosis—From experimental insights to the clinic. Nat. Rev. Drug Discov. 2021;20:589–610. doi: 10.1038/s41573-021-00198-1. - DOI - PMC - PubMed
    1. Doran A.C. Inflammation Resolution: Implications for Atherosclerosis. Circ. Res. 2022;130:130–148. doi: 10.1161/CIRCRESAHA.121.319822. - DOI - PMC - PubMed